International Clinical Trial: A multicenter, randomized, double-blind, double-dummy, placebo-controlled and active-controlled clinical study to evaluate the efficacy and safety of FNS007 for injection in patients with moderate to severe rheumatoid arthritis

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120353) titled 'A multicenter, randomized, double-blind, double-dummy, placebo-controlled and active-controlled clinical study to evaluate the efficacy and safety of FNS007 for injection in patients with moderate to severe rheumatoid arthritis' on March 12.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University People's Hospital

Condition: Rheumatoid Arthritis

Intervention: Low dose group:FNS007 60mg, Administered intravenously twice weekly for 12 weeks High dose group:FNS007 100mg, Administered intravenously twice weekly for 12 weeks Placebo control :Administered intravenously twice w...